10-QFiled 6 Nov 2026All industries
Hudson Pacific Properties, Inc.HPP
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839
Friday 6 Nov249 filings read · 217 material
10-QFiled 6 Nov 2026All industries
Hudson Pacific Properties, Inc.HPP
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Starwood Property Trust, Inc.STWD
Quarterly report (10-Q), period ending 30 Sep 2026
The gap closed as the filings read less positively.
The price trend weakened.
10-QFiled 6 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Elanco reported Q3 2026 revenue of $1.265B (+11% YoY, +9% organic constant currency), beating expectations with accelerated pricing (4%) and strong volume growth. Gross margin expanded 300 bps. Company raised full-year 2026 revenue, EBITDA, and EPS guidance and achieved 2.9x net leverage milestone.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 6 Nov 2026All industries
Bowman Consulting Group Ltd.BWMN
8-K · Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02 — Material agreement terminated
Bowman Consulting Group completed acquisition by Bernhard Capital Partners for approximately $1 billion in all-cash transaction. Company becomes privately held, common stock delisted from Nasdaq, and shareholders receive $43.00 per share.
The filings read less positively.
The shares became dearer on AIR's value read.
8-KFiled 6 Nov 2026All industries
Fluor CorpFLR
8-K · Item 2.02 — Results of operations
Fluor reported Q3 2026 revenue of $3.7B (+10% YoY), EPS of $1.16 vs. loss of $4.30 prior year, and record new awards of $10.9B (highest in company history). Backlog grew 21% to $34.3B. Company affirmed 2026 guidance.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The price trend weakened.
10-QFiled 6 Nov 2026Biotech
BIO-TECHNE CorpTECH
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026Banks
NB Bancorp, Inc.NBBK
8-K · Items 1.01, 2.03 — Material agreement
NB Bancorp completed a $100M private placement of 7.50% fixed-to-floating subordinated notes due 2036, rated BBB- by Kroll. Net proceeds ~$98.3M will support liquidity, capital ratios, dividends, and share repurchases, with at least $30M contributed to the Bank's Tier 1 capital.
The filings read more positively.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Banks
Metropolitan Bank Holding Corp.MCB
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 6 Nov 2026Banks
Peoples Financial Services Corp.PFIS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
Great Southern Bancorp, Inc.GSBC
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
10-QFiled 6 Nov 2026Banks
Qcr Holdings IncQCRH
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Biotech
Protagonist Therapeutics, IncPTGX
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
Thursday 5 Nov642 filings read · 590 material
10-QFiled 5 Nov 2026All industries
Gold.com, Inc.GOLD
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026Industrials
Vontier CorpVNT
Quarterly report (10-Q), period ending 2 Oct 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
PRVA reported Q3 2026 net income of $13.5M (+96.6% YoY) and YTD net income of $25.6M (+85.9% YoY). Company raised full-year 2026 guidance above prior high-end across all key metrics. Acquired American Choice Healthcare MSSP (36K attributed lives) and exited Montana partnership.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net income fell 38% YoY to $4.7M despite 8.2% sales growth. Gross margin contracted 100bps to 33.5%, and adjusted EBITDA margin fell 390bps to 6.6%, driven by elevated resin prices, ocean freight costs, and higher operating expenses.
Market attention has faded.
The price trend weakened.
10-QFiled 5 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Cava Group, Inc.CAVA
Quarterly report (10-Q), period ending 4 Oct 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026Industrials
Eos Energy Enterprises, Inc.EOSE
8-K · Items 2.02, 2.05 — Results of operations
The gap narrowed as the filings read less positively.
10-QFiled 5 Nov 2026Industrials
Eos Energy Enterprises, Inc.EOSE
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
8-KFiled 5 Nov 2026Biotech
Collegium Pharmaceutical, IncCOLL
8-K · Item 2.02 — Results of operations
Q3 2026: Record $216.3M quarterly revenue (+3% YoY), JORNAY PM hit record $51.9M (+24% YoY), AZSTARYS $26.5M in first full quarter post-acquisition. Pain portfolio declined 18% YoY. Company reaffirmed full-year 2026 guidance and announced $50M share repurchase.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Biotech
Vericel CorpVCEL
8-K · Item 2.02 — Results of operations
Q3 2026 revenue grew 26% to $85.4M with net income up 179% to $14.2M. Company raised full-year revenue guidance to $344–346M and adjusted EBITDA margin guidance to 28%. Strong performance across MACI, Epicel, and NexoBrid.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
White Mountains Insurance Group LtdWTM
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
8-KFiled 5 Nov 2026Industrials
Imax CorpIMAX
8-K · Item 2.02 — Results of operations
IMAX reported record Q3 2026 results: $175M revenue (+64% YoY), $117M net income (+418% YoY), 67% net margin, and $712M quarterly box office (+90% YoY). The Odyssey grossed $550M globally. System signings exceeded 100 YTD with 65% new locations.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
BlackSky reported record Q3 2026 revenue of $43M (+118% YoY), net income of $19M, and record adjusted EBITDA of $13M. Company raised full-year revenue guidance to $140–150M and adjusted EBITDA to $18–24M. Strong Gen-3 satellite demand and major contract wins drive growth.
No notable change in AIR's read.
10-QFiled 5 Nov 2026Biotech
Vericel CorpVCEL
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became dearer on AIR's value read.
The price trend weakened.
10-QFiled 5 Nov 2026Banks
Acnb CorpACNB
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
Frontdoor, Inc.FTDR
8-K · Item 2.02 — Results of operations
Q3 2026: Revenue +6% to $655M, Net Income +10% to $116M, Adjusted EBITDA +5% to $205M, EPS +16% to $1.65. Full-year guidance raised. New $1B share repurchase authorization approved.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026Software / SaaS
IBEX LtdIBEX
8-K · Item 2.02 — Results of operations
IBEX reported record Q1 FY2027 results with 16% revenue growth to $175.2M, 7 consecutive quarters of double-digit organic growth, record adjusted EBITDA of $25.2M (+29.4% YoY), and raised full-year revenue and adjusted EBITDA guidance.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026Semiconductors
ALPHA & OMEGA SEMICONDUCTOR LtdAOSL
8-K · Item 2.02 — Results of operations
Q1 FY2027 revenue of $177.8M (+4.3% QoQ, -2.6% YoY) with improved gross margins (24.5% GAAP, 25.2% non-GAAP). AI/Server segment surged 250% YoY to >20% of revenue. Operating losses narrowed. Guidance for Q2 revenue ~$180M with stable margins.
The reported numbers improved.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Core Natural Resources, Inc.CNR
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Ecovyst Inc.ECVT
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
Brighthouse Financial, Inc.BHF
8-K · Item 2.02 — Results of operations
Q3 2026 net income of $302M ($5.21/share) down 33% YoY from $453M ($7.89/share). Adjusted earnings fell 46% to $527M ($9.12/share) from $970M ($16.87/share). Annuity and life sales declined; merger completion uncertain with Outside Date extended.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
10x Genomics reported Q3 2026 revenue of $150.7M (+1% YoY), gross margin expansion to 75% from 67%, and narrowed operating losses. Company began commercial shipments of Atera platform and raised full-year 2026 revenue guidance to $625–$635M (4–6% growth excluding litigation settlements).
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Semiconductors
Applied Optoelectronics, Inc.AAOI
8-K · Item 2.02 — Results of operations
AAOI reported Q3 2026 record revenue of $269.9M (127% YoY growth), returned to GAAP profitability with $6.3M net income, and raised Q4 2026 guidance to $385–420M revenue. Secured multi-year Tier 1 hyperscale customer agreement; manufacturing capacity expanding to 500K+ units/month by end-2026.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
Howard Hughes Holdings Inc.HHH
8-K · Item 2.02 — Results of operations
Q3 2026: Net loss of $1.1M vs. $119.5M income YoY. Vantage insurance contributed $76.6M pre-tax income. Real estate EBT fell $115.5M due to prior-year bulk sale comparison and $19.4M Floreo JV loss. Company announced asset-light real estate strategy transition.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Q3 2026 revenue surged 551% YoY to $13.9M despite QoQ decline. Company expanded headcount to 340+, acquired Upgrade Energy, increased inventory to $65.9M, and maintains $162M cash. Adjusted EBITDA loss ~$0.7M; targeting profitability in 2027.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
Artivion, Inc.AORT
8-K · Item 2.02 — Results of operations
More of the market is starting to notice.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
FIGS, Inc.FIGS
8-K · Item 2.02 — Results of operations
FIGS reported Q3 2026 net revenues of $190.7M (+25.7% YoY), exceeding expectations with net income of $19.3M ($0.10 EPS) and adjusted EBITDA margin of 16.5%. Company raised full-year 2026 guidance for net revenues (~23.5% growth) and adjusted EBITDA margin (~15.8%).
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026Biotech
Allogene Therapeutics, Inc.ALLO
8-K · Item 2.02 — Results of operations
Allogene reports Q3 2026 results with continued ALPHA3 enrollment momentum, anticipated mid-2027 clinical update, expanded ALLO-329 autoimmune data presentation, and appointment of commercialization veteran. Cash position of $388.9M supports runway into 2029.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Hertz reported Q3 2026 results with strongest quarterly revenue ($2.6B, +6% YoY) and Adjusted Corporate EBITDA ($233M, +15% YoY) in three years. RPD and RPU each increased ~5% YoY with U.S. core RPD up ~8%. Liquidity at $946M.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
SkinHealth Systems reported Q3 2026 results with improved gross margins (68.2% vs 64.6% YoY), reduced net loss ($0.9M vs $11.0M), and higher adjusted EBITDA ($13.4M vs $8.9M). Consumables returned to growth; company retired $103.2M debt. Revenue declined 2.1% YoY to $69.2M.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
James Hardie Industries plcJHX
8-K · Item 2.02 — Results of operations
AIR measured this for the first time; no change to report.
More of the market is starting to notice.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 earnings exceeded prior year across key metrics: sales +14.3% YoY to $587.2M, net income +24.2% to $26.9M, diluted EPS $1.64 vs $1.31, Adjusted EBITDA +19.0% to $67.3M. Five acquisitions completed; strong cash position of $218.8M.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Howard Hughes Holdings Inc.HHH
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Items 1.01, 2.03 — Material agreement
TD SYNNEX entered into a $1.75B senior unsecured term loan on November 2, 2026, maturing November 2, 2029. Proceeds refinanced a $750M maturing loan and provide $1B for general corporate purposes and acquisitions.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Cronos reported Q3 2026 record net revenue ($63.5M, +75% YoY), gross profit, and Adjusted EBITDA while reducing share count. Spinach maintained #1 market share in Canadian vapes/edibles; Israel delivered 11th consecutive record quarter; Germany showed 614% YoY growth.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Industrials
Simpson Manufacturing Co., Inc.SSD
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
8-KFiled 5 Nov 2026All industries
Priority Technology Holdings, Inc.PRTH
8-K · Item 2.02 — Results of operations
Q3 2026 revenue grew 11.3% YoY to $268.6M, but net income fell 55.7% to $12.2M. Gross margins compressed ~110 bps. Company announced go-private transaction at $8.05/share and suspended forward guidance due to pending deal.
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
WillScot exceeded Q3 2026 revenue and Adjusted EBITDA outlook. Revenue $601M, Adjusted EBITDA $234M (38.8% margin, +160 bps sequentially). Raised FY2026 revenue guidance to $2.34B. Modular activations up 12% YoY; Enterprise Accounts revenue +15% YoY. Expects mid-single digit Adjusted EBITDA growth in 2027.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Industrials
Enovis CORPENOV
Quarterly report (10-Q), period ending 2 Oct 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026Industrials
DANA IncDAN
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenue grew 15.7% YoY to $772.6M with gross margin expansion to 44.6%. Net income surged to $52.4M ($0.72 EPS) vs. $20.5M ($0.29 EPS) prior year. Company raised FY2026 revenue and Adjusted EPS guidance.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 revenues grew 9.3% YoY to $511.1M; Adjusted OIBDA increased 5.9% to $145.3M; net income rose 26.3% to $64.8M. Transit segment surged 84.1% in Adjusted OIBDA. Company expects double-digit 2026 revenue growth.
Market attention has faded.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
The reported numbers weakened.
Market attention has faded.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
White Mountains Insurance Group LtdWTM
8-K · Item 2.02 — Results of operations
Q3 2026 book value declined 1% despite solid operating results. MediaAlpha investment losses ($54M unrealized), higher interest rates reducing portfolio fair values, and property market softening drove results below prior year comparisons.
The gap narrowed as the filings read less positively.
8-KFiled 5 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
Q1 FY27 revenue grew 13% YoY to $353.8M, beating August guidance. Core revenue grew 14% YoY. Non-GAAP operating income surged 101% YoY to $136.9M, significantly exceeding outlook. Company raised full-year guidance.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net income fell 27% YoY to $40.2M; revenue declined 18.7% to $217.6M. Nine-month net income rose 159% YoY but includes $52.3M non-cash benefit from HaloMD contract amendment. Operating cash flow declined 21% in Q3.
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 5 Nov 2026Banks
8-K · Item 2.02 — Results of operations
Affirm reported FQ1'27 results with 35% revenue growth to $1.26B, 12th consecutive quarter of >30% GMV growth to $14.4B, and 8 consecutive quarters of GAAP profitability. Adjusted operating income grew 44% to $380M with 30% margin. Affirm Card GMV surged 117% to $3.3B with 6M active cardholders (+112% YoY).
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
10-QFiled 5 Nov 2026All industries
Ingevity CorpNGVT
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The price trend weakened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
8-KFiled 5 Nov 2026All industries
Lemonade, Inc.LMND
8-K · Item 2.02 — Results of operations
Q3 2026 results show strong operational momentum: IFP grew 34% YoY to $1.55B (12th consecutive quarter of acceleration), revenue surged 73% to $336M, gross profit jumped 48% to $118M. Company reiterates path to positive Adj. EBITDA in Q4 2026 and raises FY26 GEP and revenue guidance.
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Biotech
Eton Pharmaceuticals, Inc.ETON
8-K · Item 2.02 — Results of operations
Eton reported record Q3 2026 revenue of $57.9M (158% YoY growth), surpassed $200M annualized run-rate goal five quarters early, achieved 49% Adjusted EBITDA margin, and raised full-year 2026 revenue guidance to >$175M and Adjusted EBITDA margin guidance to >40%.
The shares became cheaper on AIR's value read.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Shift4 announced Q3 2026 financial results. CEO acknowledges 40% YTD share price decline and shareholder pain, emphasizing business durability and capital allocation strategy. Specific financial metrics not disclosed in provided excerpt.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
MP Materials reported Q3 2026 results with 176% revenue growth to $147.7M, NdPr production up 41% YoY, and completed GM magnet qualification with saleable deliveries commencing Q4. Adjusted EBITDA swung to $41.1M positive from $(12.6)M loss YoY.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
The price trend strengthened.
10-QFiled 5 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026Software / SaaS
Grindr Inc.GRND
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $141M (+22% YoY) beats expectations. Company raises full-year 2026 guidance to $560M revenue and $236M Adjusted EBITDA, achieving 2024 Investor Day targets early. Completed Freddie acquisition to expand telehealth. Launching Edge AI premium tier.
No notable change in AIR's read.
8-KFiled 5 Nov 2026Software / SaaS
Certara, Inc.CERT
8-K · Item 2.02 — Results of operations
Certara reported Q3 2026 revenue of $94.9M (+4% YoY) with software revenue growing 11% organically—first double-digit quarter in two years. Net loss improved 26%. Adjusted EBITDA margin expanded 370bps to 31.8%. Full-year guidance narrowed to 2–3% revenue growth; adjusted EPS raised to $0.31–$0.34.
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 5 Nov 2026All industries
8-K · Item 1.01 — Material agreement
Prospect Capital issued $300M in 8.95% senior unsecured notes due 2031. Net proceeds (~$283.4M) will refinance existing debt and maintain liquidity. Standard debt offering with no operational or strategic changes disclosed.
No notable change in AIR's read.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net loss of $9.2M vs. prior-year profit of $18.1M. Legacy MasterBrand sales down 2.5% YoY amid market softness. Gross margin compressed 660 bps. Q4 guidance implies continued losses. Integration ahead of schedule but insufficient to offset demand headwinds.
The gap narrowed — attention is catching up.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
NorthWestern Energy Group, Inc.NWE
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 5 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
StandardAero reported Q3 2026 results with 36.2% net income growth, 30% adjusted EPS growth, and 15% adjusted EBITDA growth. Company raised full-year 2026 guidance and announced $350M accelerated share repurchase program with $1B total authorization.
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Ategrity Specialty Insurance Co HoldingsASIC
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 5 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 5 Nov 2026All industries
8-K · Item 2.02 — Results of operations
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.